Levoxyl Tablets Recalled for Low Potency at Expiry
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves subpotency (low potency) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
King Legacy, a wholly owned subsidiary of Pfizer, is recalling Levoxyl (levothyroxine sodium) tablets. The affected products are 50 mcg tablets packaged in 100-count and 1000-count bottles. The recall involves 195,699 bottles distributed nationwide and in Puerto Rico.
The recall was initiated because the products were below specification for potency at the expiry stability point. This means the medication may not contain the full intended amount of the active ingredient when it reaches its expiration date.
Consumers with these specific lot numbers should contact their healthcare provider or pharmacist for guidance on replacement or alternative treatment. The affected lots include 64934, 65059, 65179, 65630, 65916, 66367, 66718, 64338, 64932, 65060, 65235, 65853, and 65962.
The recalled product
- Product
- LEVOXYL (LEVOTHYROXINE SODIUM)
- Brand
- LEVOXYL
- Manufacturer
- King Legacy, a wholly owned subsidiary of Pfizer
- Category
- Drug — Thyroid Hormone
- Hazard
- Affected units
- 195,699
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # a) 64934
- Exp. 4/13
- 65059
- Exp. 5/13
- 65179
- 65630
- Exp. 7/13
- 65916
- Exp. 8/13
- 66367
- Exp. 10/13
- and 66718
- Exp. 11/13
- b) 64338
- 64932
- 65060
- 65235
- Exp. 6/13
- 65853
- and 65962
UPCs (11)
- 0360793856018
- 0360793850016
- 0360793852010
- 0360793851013
- 0360793857015
- 0360793853017
- 0360793854014
- 0360793858012
- 0360793855011
- 0360793859019
- 0360793860015
Distribution
Part of a larger recall action
This product is one of 11 recalled by King Legacy, a wholly owned subsidiary of Pfizer under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same brand · LEVOXYL
- HighLevoxyl 50 microgram levothyroxine tablets recalled as a subpotent drug
FDA (Drugs) · 2025-08-20
- ModerateCardinal Health Recalls LEVOXYL Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SeverePfizer Recalls Levoxyl Levothyroxine Sodium Tablets Due to Superpotency
FDA (Drugs) · 2018-12-26
- SeverePfizer Recalls LEVOXYL Levothyroxine Sodium Tablets Due to Superpotency
FDA (Drugs) · 2016-11-30
- ModerateLevoxyl Levothyroxine Sodium Tablets Recalled for Low Potency
FDA (Drugs) · 2013-05-29
Same manufacturer · King Legacy, a wholly owned subsidiary of Pfizer
See all →- HighLevoxyl Levothyroxine Sodium Tablets Recalled for Low Potency
FDA (Drugs) · 2013-05-29
- ModerateLevoxyl Levothyroxine Sodium Tablets Recalled for Subpotency
FDA (Drugs) · 2013-05-29
- ModerateLevoxyl Tablets Recalled for Low Potency at Expiry
FDA (Drugs) · 2013-05-29
- HighLevoxyl Tablets Recalled for Low Potency at Expiry
FDA (Drugs) · 2013-05-29
- ModerateKing Legacy Recalls Subpotent Levoxyl Levothyroxine Sodium Tablets
FDA (Drugs) · 2013-05-29
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22